My research primarily focuses on investigating new therapies for Chronic Myeloid Leukaemia and the roles of auto-antigens, in early-stage and advanced cancers, with the aim of identifying novel cancer biomarkers and potential targets for targeted anti-Cancer Immunotherapies.
My current research is focused on enhancing sensitivity and specificity of molecular detection of SARs-CoV-2 variants
I am currently the director of a UK Masters program in Medical Molecular Biology with Genetics. I also deliver undergraduate and postgraduate teaching, in human immunology and molecular genetics and supervise researchers and research projects associated with the Bangor University, School of Medical and Health Sciences, PhD, MRes, MSc and Masters degree programs.
I have been an examiner of UK PhD student thesis and MSc Masters programs, and a member of external validation panels for international BSc, MSc and PhD programs.
Staff webpage https://www.bangor.ac.uk/medical-sciences/staff/david-pryce/en